Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report

Autor: Vondrák, K., Seeman, T.
Zdroj: In Transplantation Proceedings April 2018 50(3):967-970
Databáze: ScienceDirect